Department of Tumor Intervention, Renji Hospital, Associate Chief Physician, Master's Supervisor Long-term engagement in comprehensive tumor treatment and minimally invasive interventional clinical diagnosis and treatment, with a focus on precision minimally invasive ablation therapy for thyroid nodules and breast nodules, and expertise in minimally invasive ablation for thyroid nodules, thyroid adenomas, thyroid cancer, and breast nodules. 【Research Achievements】 As first author and corresponding author, published 15 research articles in SCI journals such as Hepatology and J Exp Clin Cancer Res, and 5 papers in Chinese core journals; presided over and participated in 2 projects funded by the National Natural Science Foundation of China; presided over 1 project funded by the Ministry of Education Postdoctoral Science Foundation General Program; presided over 1 doctoral special project of Shanghai Renji Hospital and 1 National Natural Science Foundation cultivation project; participated in multiple projects funded by the Ministry of Science and Technology of China, the National Natural Science Foundation of China, and the Shanghai Municipal Science and Technology Commission; contributed to 1 monograph: "General Practice Medicine." 【Research Directions】 1. Biopsy and ablation therapy for benign and malignant tumors of the thyroid and parathyroid glands, including thyroid nodules, thyroid cancer, nodular goiter, parathyroid tumors, primary and secondary hyperthyroidism and hyperparathyroidism, etc.; 2. Sclerotherapy and ablation therapy for cystic nodules of the thyroid and parathyroid glands, hepatic cysts, renal cysts, and ovarian cysts; salvage ablation therapy for postoperative tumor residue and recurrent thyroid cancer after thyroid cancer surgery; 3. Biopsy and ablation therapy for breast fibroadenomas and benign nodules, and ablation therapy for recurrent and metastatic breast cancer; 4. Multidisciplinary precision comprehensive treatment for various advanced and refractory malignant tumors including lung cancer, liver cancer, gallbladder cancer, pancreatic cancer, gastric cancer, colorectal cancer, and renal cancer, including targeted therapy, chemotherapy, immunotherapy, and combined interventional and ablation therapy.